Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The hypothesis of this study is that a reduced extrafascial volume of local anesthetic for an interscalene brachial plexus block is associated with a lower incidence of diaphragmatic hemiparalysis after an arthroscopic surgery of the shoulder, without any reduction of the analgesic efficacy.
The hypothesis of this study is that a reduced extrafascial volume of local anesthetic for an interscalene brachial plexus block is associated with a lower incidence of diaphragmatic hemiparalysis after an arthroscopic surgery of the shoulder, without any reduction of the analgesic efficacy.
Our prospective randomized controlled trial will include two parallel groups: a group will receive a volume of 20 mls of ropivacaine 0.75%, while the other group will receive a volume of 10 mls.
All participants will have a preoperative ultrasound-guided interscalene brachial plexus with an extrafascial injection of 10 or 20 mls of ropivacaine 0.75%. In both groups, participants will have an examination of the hemidiaphgragm with the ultrasound, before and 30 min after the block. The respiratory function will also be assessed with a bedside spirometer before and after the block, and at 12 and 24 postoperative hours. During surgery all participants will receive multimodal analgesia inclusive of iv dexamethasone 8 mg, iv magnesium sulfate 40 milligram kg^2, iv ketorolac 30 milligrams, and iv acetaminophen 1000 milligrams, according to the current practice in our institution. In the postoperative period, Participants will be prescribed an IV pca of morphine.
Assignment to one of these two groups will be done according to a computer-generated list of random numbers, and the sealed envelopes method will be used.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 10 ml single-shot injection | Experimental | In the 10ml group, participants will have an interscalene brachial plexus with an extrafascial injection of 10 ml ropivacaine 0.75% at the level of C5-C6 nerves roots. Participants will also receive multimodal analgesia with injection of dexamethasone 8 mg iv, magnesium sulfate 40 mg kg^-1 iv, ketorolac 30 mg iv, and acetaminophen 1000 mg iv, according to the current practice in our institution. |
|
| 20 ml single-shot injection group | Active Comparator | In the 20ml group, participants will have an interscalene brachial plexus with an extrafascial injection of 20 ml ropivacaine 0.75% at the level of C5-C6 nerves roots. Participants will also receive multimodal analgesia with injection of dexamethasone 8 mg iv, magnesium sulfate 40 mg kg^-1 iv, ketorolac 30 mg iv, and acetaminophen 1000 mg iv, according to the current practice in our institution. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Ropivacaine 0.75% Injectable Solution | Drug | 10 ml extrafascial interscalene brachial plexus block |
|
| Measure | Description | Time Frame |
|---|---|---|
| Incidence of hemidiaphragmatic paralysis | 30 minutes after the interscalene plexus brachial extrafascial injection |
| Measure | Description | Time Frame |
|---|---|---|
| Incidence of hemidiaphragmatic paralysis | at 2 and 24 postoperative hours | |
| Presence of Dyspnea | Verbal question to the patient if he has dyspnea or not | in phase 1 recovery and at 12 and 24 postoperative |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHUV (Centre Hospitalier Universitaire Vaudois) | Lausanne | Canton of Vaud | 1011 | Switzerland |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 39855930 | Derived | Renard Y, Grape S, Gonvers E, Rossel JB, Goetti P, Albrecht E. Respiratory impact of local anaesthetic volume after interscalene brachial plexus block with extrafascial injection: a randomised controlled double-blinded trial. Br J Anaesth. 2025 Apr;134(4):1153-1160. doi: 10.1016/j.bja.2024.12.010. Epub 2025 Jan 23. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000077212 | Ropivacaine |
| ID | Term |
|---|---|
| D000813 | Anilides |
| D000577 | Amides |
| D009930 | Organic Chemicals |
| D000814 | Aniline Compounds |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Ropivacaine 0.75% Injectable Solution | Drug | 20 ml extrafascial interscalene brachial plexus block |
|
| Presence of PONV | Verbal question to the patient if he has dyspnea or not | in phase 1 recovery and at 12 and 24 postoperative |
| Presence of Pruritus | Verbal question to the patient if he has pruritus or not | in phase 1 recovery and at 12 and 24 postoperative hours |
| Presence of Claude-Bernard-Horner syndrome | Examination of the patient | in phase 1 recovery and at 12 and 24 postoperative hours |
| Presence of Dysphonia | Verbal question to the patient if he has dysphonia or not | in phase 1 recovery and at 12 and 24 postoperative hours |
| Forced expiratory volume in one second | in liters per second | 30 minutes after the interscalene plexus brachial extrafascial injection, and at 2, 12 and 24 postoperative hours |
| Forced vital capacity | in liters | 30 minutes after the interscalene plexus brachial extrafascial injection, and at 2, 12 and 24 postoperative hours |
| Peak expiratory flow | in liters per second | 30 minutes after the interscalene plexus brachial extrafascial injection, and at 2, 12 and 24 postoperative hours |
| Installation time of sensory block | in minutes | up to 30 minutes after the interscalene plexus brachial extrafascial injection |
| Installation time of motor block | in minutes | up to 30 minutes after the interscalene plexus brachial extrafascial injection |
| Time to first dose of postoperative iv morphine | in hours | up to 24 hours postsurgery |
| Pain scores at rest | Numeric pain intensity scale. Pain scores range from zero (no pain) to 10 (worst possible pain) | in phase 1 recovery and at 12 and 24 postoperative hours |
| Pain scores on movement | Numeric pain intensity scale. Pain scores range from zero (no pain) to 10 (worst possible pain). | in phase 1 recovery and at 12 and 24 postoperative hours |
| Cumulative postoperative iv morphine consumption | in milligrams | in phase 1 recovery and at 12 and 24 postoperative hours |
| Duration of analgesic block | in minutes | up to 24 hours postsurgery |
| Duration of motor block | in minutes | up to 24 hours postsurgery |
| Duration of sensory block | in minutes | up to 24 hours postsurgery |
| Satisfaction of the participants | Numeric satisfaction intensity scale. Satisfactions range from 0 (totally unsatisfied) to 10 (maximal satisfaction). | at 24 postoperative hours |
| D000588 |
| Amines |